James D Phelan

8PUBLICATIONS
64CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 31, 2026
Phosphorylation Protects Oncogenic RAS from LZTR1-Mediated Degradation.

|Jul 18, 2025
BLIMP1 negatively regulates IL-2 signaling in T cells.

Suyasha Roy, Min Ren, Peng Li

|Jul 18, 2024
Gα13 restricts nutrient driven proliferation in mucosal germinal centers.

Hang T Nguyen, Moyi Li, Rahul Vadakath

|Apr 29, 2024
Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma.

Sean R Corcoran, James D Phelan, Jaewoo Choi

|Apr 18, 2024
Primary large B-cell lymphomas of immune-privileged sites.

Mark Roschewski, James D Phelan, Elaine S Jaffe

|May 04, 2023
Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas.

Sebastian Scheich, Jiji Chen, Jiamin Liu

Pageof 2

Frequent Collaborators

4 joint publications

Jagan R Muppidi

4 joint publications

Thomas Oellerich

3 joint publications

Ryan M Young

2 joint publications

Arnold Bolomsky